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PETThe amyloid imaging agent, Pittsburgh Compound-B, bindswith high afﬁnity toβ-amyloid (Aβ) in the brain, and
it is well established that PiB also shows non-speciﬁc retention in white matter (WM). However, little is known
about retention of PiB in areas of white matter hyperintensities (WMH), abnormalities commonly seen in older
adults. Further, it is hypothesized that WMH are related to both cognitive dysfunction and Aβ deposition. The
goal of the present study was to explore PiB retention in both normal-appearing WM (NAWM) and WMH in a
group of elderly, cognitively normal individuals. In a group of cognitively normal elderly (n = 64; 86.5 ±
2.6 years) two analyses were applied: (1) ROIs were placed over periventricular areas in which WMH caps are
commonly seen on all subjects, regardless of WMH burden or size. (2) Subject-speciﬁc maps of NAWM and
WMH were co-registered with the PiB-PET images and mean SUVR values were calculated in these NAWM
and WMHmaps. PiB retention was signiﬁcantly reduced in the ROIs of subjects with high WMH compared to
subjects with low WMH. Additionally, in subjects with high WMH, there was signiﬁcantly lower PiB retention
in subject-speciﬁcmaps ofWMHcompared toNAWM,whichwas not observed in subjectswith lowWMH, likely
because of the small size ofWMHmaps in this group. These data suggest thatWM in areas ofWMHbinds PiB less
effectively than does normalWM. Further exploration of this phenomenonmay lead to insights about themolec-
ular basis of the non-speciﬁc retention of amyloid tracers in white matter.
© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Pittsburgh Compound-B bindswith high afﬁnity to ﬁbrillar amyloid-
beta (Aβ) in the brain (Mathis et al., 2013). Thus, PiB provides amethod
of detecting and quantifying β-amyloid deposition in living subjects
(Klunk et al., 2004). PiB studies have shown a 2-fold increase in tracer
retention in Alzheimer disease (AD) cases compared to cognitively nor-
mal controls (for review see Cohen et al., 2012). Further, it also well
established that PiB shows signiﬁcant white matter retention, but this
binding does not appear to be related to Aβ deposits (Klunk et al.,
2004), and, interestingly, the absence of PiB has been shown tomark de-
myelinating lesions in models of multiple sclerosis and in humans with
multiple sclerosis (Stankoff et al., 2011).
Little is known, however, about retention of PiB in areas of white
matter hyperintensities (WMH). WMH are areas of increased signal in-
tensity seen on T2-weighted magnetic resonance (MR) images
(Gorelick et al., 2011). While the precise aetiology of WMH is debatedInstitute and Clinic, Pittsburgh
6.
. This is an open access article under(Scarpelli et al., 1994; Scheltens et al., 1995), these abnormalities are com-
monly thought to be a manifestation of subclinical vascular disease
(Gorelick et al., 2011). Additionally, WMH are one of the most common
pathological changes associated with aging (de Leeuw et al., 2001), and
thepresence ofWMHshavebeen reported as risk factor formild cognitive
impairment (MCI) and AD (Yoshita et al., 2006). Neuropathologically,
WMH have correlated primarily with demyelination but also with arte-
riosclerosis, axon loss, gliosis, dilated perivascular spaces, spongiosis,
and lacunar infarcts (Chimowitz et al., 1992; Munoz et al., 1993;
Scarpelli et al., 1994; Young et al., 2008). In a recent pathological study
of cognitively normal controls, it was observed that vacuolation, de-
creased myelin density and decreased small vessel density contribute to
the presence of WMH, while factors such as axonal density and glial cell
burden did not (Murray et al., 2012). Further, posterior WMH have
been found to be associated pathologically conﬁrmed cerebral amyloid
angiopathy (Thanprasertsuk et al., 2014).
Given the importance of both amyloid deposition and white matter
lesions in the pathogenesis of AD and normal aging, it is critical to un-
derstand the binding properties of PiB to both normal and abnormal
white matter. The goal of the present report is to explore PiB retentionthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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ly, cognitively normal individuals.2. Materials and methods
2.1. Human subjects
Participants were recruited from the Ginkgo Evaluation of Memory
Study (GEMS, September 2000 through April 2008), a multisite,
placebo-controlled, double-blind, randomized clinical trial of the daily
use of Ginkgo biloba in 3069 community-dwelling participants aged
72–96 years at baseline (DeKosky et al., 2006). From July 2010 through
November 2012, a total of 81 of these participants who remained
nondemented were recruited for a neuroimaging assessment. For
these analyses, we included the 64 cognitively normal elderly partici-
pants from this substudy, that were studied with PiB-PET, had visual
WMH scores (Longstreth et al., 1996) and had FLAIR MRIs available
for analysis. The average age of this subset of the complete cohort
(n = 64) was 86.5 ± 2.6 years. All subjects were deﬁned as cognitively
normal by a neuropsychologist (Dr. Snitz) reviewing clinical testing
data and blind to all neuroimaging data, with a mean MMSE value of
28.5 ± 1.3. All subjects provided informed consent for both the clinical
examination and PET imaging. All studieswere approved by the Human
Use Subcommittee of the RadioactiveDrug Research Committee and the
Institutional Review Board of the University of Pittsburgh.2.2. Imaging studies
Prior to PiB-PET, a structural 3 T spoiled-gradient-recalled-MR was
obtained for each subject for co-registration and region-of-interest
(ROI) deﬁnition. MRI scanning was performed using a GE Signa 1.5 T
scanner (GE Healthcare, Waukesha, WI) and a standard head coil
(Price et al., 2005) including ﬂuid-attenuated inversion recovery (echo
time= 172milliseconds (ms), repetition time= 9004ms) and spoiled
echo gradient (echo time = 5 ms, repetition time = 25 ms) images.
[11C]PiB was produced as previously described (Price et al., 2005).
PET imaging was conducted using a Siemens/CTI ECAT HR+ (3D
mode, 15.2 cm ﬁeld-of-view, 63 planes, reconstructed image resolution
~6 mm FWHM). The subject3s head was immobilized to minimize head
motion. PiB was injected intravenously (12–15 mCi, over 20 s, speciﬁc
activity ~1–2 Ci/µmol), and PET scanning was performed over
40–70 min. Analysis of the PiB-PET data resulted in regional standard-
ized uptake value ratios (SUVRs) computed using cerebellum as refer-
ence (determined 50–70 min post-injection) (McNamee et al., 2009).
SUVRs referenced to pons were also computed.
The baseline full resolution MRIs were resliced along the AC–PC line
and down-sampled to PET voxel space. After addressing any motion ar-
tefact, the PiB-PET data were summed to form a static image and co-
registered to the down-sampled FLAIR MR image.2.3. Region of interest analysis
2.3.1. Region of interest analysis
Two types of ROIs were generated. First, ROIs of consistent dimen-
sions (oval shape, 8.87 cm3) (referred to as “standardized” ROIs) were
created. These standardized ROIs were placed over areas anterior and
posterior to the lateral ventricles, in areas where periventricular WMH
caps are characteristically seen, using the downsampled FLAIR MRIs.
These ROIs were of consistent size for all subjects, regardless of WMH
burden or size (Fig. 1). A second ROI analysis was generated by tracing
areas of obvious, discrete periventricular WMH (referred to as “hand-
traced” ROIs). In this hand-traced analysis, standardized ROIs were
used in areas without clearly demarcated WMH. All ROIs were created
and placed by a single investigator (AEG, Fig. 1).2.3.2. Subject speciﬁc white matter maps
We used an automated intensity-based segmentation method, with
a 3-class model (gray matter, white matter, and cerebrospinal ﬂuid) to
identify the white matter on the MPRAGE image. This white matter
mask was registered to the PIB-PET space using a 12-parameter afﬁne
registration, with the normalized mutual information cost function
(Jenkinson et al., 2002). The T2-weighted FLAIR image was used to seg-
ment this white matter mask into WMH, and normal appearing white
matter (NAWM). The automated WMH segmentation method (Wu
et al., 2006) is an iterative algorithm that involves an automated selec-
tion of “seeds” of possible WMH lesions and fuzzy connectedness,
which clusters voxels based on their adjacency and afﬁnity, to segment
WMH lesions around the seeds (Udupa et al., 1997). These subject-
speciﬁc maps WMHmaps were then co-registered to the MPRAGE im-
ages, and to PiB-PET space (using the transformation from MPRAGE to
PiB-PET space), and mean SUVR values were calculated for the WMH
ROIs, and for the remaining white matter (NAWM).2.4. Classiﬁcation of WMH
Participants were stratiﬁed into two groups, high WMH and low
WMH, based on the visual classiﬁcation of WMH based on the Cardio-
vascular Health Study (CHS) visual ratings of WMH (Longstreth et al.,
1996). White matter changes were visually estimated and compared
to standards by the total extent of periventricular and subcortical
white-matter signal abnormality on axial FLAIR images and graded by
successive increase from barely detectable (Grade 1) to almost all
white matter involved (Grade 9) (Yue et al., 1997), these ratings were
performed by two experienced clinicians (WEK and OLL). A WMH
grade ≥3 was considered to have high WMH burden.2.5. Statistical analyses
All statistical analyseswere conducted in the Statistical Analysis Sys-
tem (SAS), Version 9.3. Two-sample, two-tailed t-tests were performed
for between group comparisons, and tests for correlation were per-
formed using Pearson correlations.3. Results
3.1. Region of interest analysis
Signiﬁcantly lower PiB retention was observed in periventricular
areas in subjects with visual rating scores indicating high WMH
(p b 0.05). In both anterior and posterior ROIs there was signiﬁcantly
lower PiB retention when those with high WMH were compared to
those with low WMH (Figs. 1 and 2), which was seen using both the
hand-traced (Fig. 2A) and standardized ROI analyses (Fig. 2B). There
were no consistent differences observed between PiB uptake the anteri-
or and posterior periventricular regions in any of the ROI analyses. Fur-
ther, there was a signiﬁcant relationship between PiB SUVR in the WM
ROIs and the visual WM rating scores, with higher scores (moreWMH)
being correlated with lower PiB SUVR (data from standardized ROIs
shown in Fig. 3). Additionally, similar results were seen when using a
pons reference region (data not shown).3.2. Subject speciﬁc white matter maps
In subjects with substantialWMH (i.e., visual grade≥3), signiﬁcant-
ly lower PiB retention was observed in the WMHmap when compared
to the NAWMmap (Fig. 4). This relationship could not be tested in the
subjects with visual grade b3 since there was an insufﬁcient number
of WMH voxels to make the comparison statistically robust.
Fig. 1. Representative FLAIR MRI and PiB-PET images for WMH(−)/ PiB(−), WMH(−)/ PiB(+),WMH(+)/ PiB(−), and WMH(+)/ PiB(+). The standardized ROIs can be seen in the
WMH(−) FLAIR images. The hand-traced ROIs can be seen in the WMH(+) images.
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In the present study PiB retention was signiﬁcantly reduced in the
periventricular ROIs of subjects with high WMH compared to subjects
with lowWMH. Additionally, in subjectswith highWMH, therewas sig-
niﬁcantly lower PiB retention in subject-speciﬁc maps of WMH com-
pared to NAWM.Fig. 2. (a) PiBwas signiﬁcantly lower in the hand-tracedWMHROIs of highWMH subjects [WM
lower in the standardized WMH ROIs of high WMH subjects [WMH(+)] compared to sub
periventricular WM, light gray bars indicate PiB retention in posterior periventricular WM, an
(total WM). ***p b 0.001 **p b 0.01 *p b 0.05.A simple explanation for the present ﬁndings is that a reduction in
blood ﬂow as a result of vascular disease, represented by WMH, could
reduce PiB retention in the WM of individuals with signiﬁcant WMH.
However, we believe that this in unlikely for two reasons. First, if
these changes were a result of blood ﬂow, then it is likely that a reduc-
tion in cortical PiB would have been observed in addition to the reduc-
tion in PiB observed in the WMH and this is not the case — cortical PiBH(+)] compared to subjects with lowWMHburden [WMH(−)]. (b) PiBwas signiﬁcantly
jects with low WMH burden [WMH(−)]. Black bars indicate PiB retention in anterior
d dark gray bars indicate PiB retention in both anterior and posterior periventricular WM
Fig. 3. PiB retention in theWMHROIs was signiﬁcantly correlatedwith visualWMratings.
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cantly different (data not shown). Second, when we examined regional
cerebral bloodﬂow (rCBF) using arterial spin labelling, therewas no sig-
niﬁcant difference in rCBF in any of the WM ROIs between those with
high and lowWMH, and there was no correlation between rCBF in the
WM ROIs and visual WMH rating or PiB in the WM (data not shown).
Additionally, a comparison of a global cortical rCBF ROI between those
with high and low WMH, showed no signiﬁcant difference between
the two groups.
A more likely explanation for these results is that WM in areas of
WMH may have different binding characteristics to PiB than does nor-
mal WM. Indeed, Stankoff et al. (2011) have demonstrated that PiB
binding in both animal and human brain sections depends on the
amount ofmyelin present and that PiB-PET inmultiple sclerosis patients
showed decreased PiB binding to demyelinated lesions. The authors
suggest that PiB binding to WM is at least in part related to binding to
the beta-sheet structure of myelin basic protein. The data in the present
study would also support this notion, as several post-mortem studies
have demonstrated a degradation of myelin basic protein in areas of
WMH(Murray et al., 2012; Yamamoto et al., 2009).While themolecularFig. 4. PiB retention was signiﬁcantly lower in the WMH maps compared to the NAWM
maps in WMH(+) subjects. Black bars indicate NAWM and gray bars indicate WMH.
***p b 0.001.basis of binding of PiB to WM andWMH remains unknown, these data
suggest that further exploration of this phenomenon may lead to in-
sights about the molecular basis of this non-speciﬁc interaction.
Clinically, these results are of interest in several ways. First, as PiB
has been shown to have decreased binding in areas of demyelination
(Stankoff et al., 2011), these results suggest that PiB may be binding to
myelin and that decreased binding in areas of WMH adds to the previ-
ous evidence of myelin damage in WMH (Murray et al., 2012;
Yamamoto et al., 2009). Additionally, this study is one of few that uses
amyloid tracers to study white matter. The potential for these agents
to be used to study white matter is a subject that should be further ex-
plored and is of potential future clinical use. Finally, the distinction be-
tween speciﬁc cortical gray matter and non-speciﬁc white matter
binding of amyloid imaging agents has been utilized clinically in visual
read procedures to distinguish amyloid positive vs. amyloid negative
scans. Understanding the role signiﬁcant WMH play in the non-
speciﬁc binding of amyloid imaging agents toWMwill be of critical im-
portance to ensure accurate visual assessment of amyloid PET scans.
From a technical perspective, the use of whitematter containing ref-
erence regions for analysis of amyloid imaging data could be of concern
in a population with high WMH. Further, analysis of longitudinal data
utilizing WM containing regions as a reference could be challenging
due to changes in WMH over time. However, because this study ex-
plored periventricular WMH and not subcortical or cerebellar white
matter disease, this questions warrants further investigation. Addition-
ally, it is possible that in participants with extensive periventricular
WMH, quantiﬁcation of cortical PiB may become diluted due to volume
averaging, a situation thatmight be exacerbating by the presence of sig-
niﬁcant atrophy that might also dilute the PiB signal.
There are several limitations to this study. First, the advanced age of
our cohort (N85 years) makes it difﬁcult to make conclusions regarding
PiB binding toWM in younger elderly or young adults. Additionally, it is
well established that this cohort has a higher proportion of PiB-
positivity (N50%) than younger, elderly cohorts (Mathis et al., 2013).
This increased proportion of PiB-positives makes analysis of the effects
of amyloid positivity on PiB-retention in the WM difﬁcult because of
the small number of PiB-negatives in each group. Second, the lack of
partial volume correction of these data could conceivably result in re-
duced PiB retention particularly in periventricular areas in subjects
with WMH.
This study is among theﬁrst to demonstrate that PiB appears to have
different binding characteristics for WMH and NAWM. Recently, one
study demonstrated a reduction in both glucosemetabolism and PiB re-
tention in gray matter regions connected to abnormal WM, however,
PiB retention within areas with WMH was not explored (Glodzik
et al., 2014). While further molecular study regarding the molecular
basis of this interaction is needed, it is possible that PiB binding to my-
elin basic protein underlies the Aβ-independent interaction of PiB to
WM, and because WMH contain degraded myelin basic protein, this
may result in a disruption of the interaction between PiB and WM.
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